XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Collaborative Agreements (Details 7) (Takeda, USD $)
1 Months Ended 9 Months Ended
Mar. 31, 2015
item
Mar. 31, 2015
item
Collaborative Agreements disclosures    
Payments received under collaboration agreement $ 31,400,000us-gaap_ProceedsFromCollaborators  
Right-to-test agreement
   
Collaborative Agreements disclosures    
Number of single-target licenses 2imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
 
Term of agreement 3 years  
Term of extension of the agreement 1 year  
Payments to be made for extension of agreement 4,000,000imgn_PaymentsForCollaboratorsContractExtension
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
 
Payments received under collaboration agreement 20,000,000us-gaap_ProceedsFromCollaborators
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
 
Right-to-test agreement | Maximum
   
Collaborative Agreements disclosures    
Potential milestone payments 210,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
210,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
Right-to-test agreement | Development milestones | Maximum
   
Collaborative Agreements disclosures    
Potential milestone payments 30,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
30,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_DevelopmentMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
Right-to-test agreement | Regulatory milestones | Maximum
   
Collaborative Agreements disclosures    
Potential milestone payments 85,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_RegulatoryMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
85,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_RegulatoryMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
Right-to-test agreement | Sales milestones | Maximum
   
Collaborative Agreements disclosures    
Potential milestone payments 95,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_SalesMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
95,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_SalesMilestonesMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
Right-to-test agreement | Option To Expand Agreement
   
Collaborative Agreements disclosures    
Payments to be made for extension of agreement 8,000,000imgn_PaymentsForCollaboratorsContractExtension
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementMember
/ us-gaap_TypeOfArrangementAxis
= imgn_RightToTestMember
 
Development and Commercialization License
   
Collaborative Agreements disclosures    
Discount rate (as a percent) 13.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Estimated utilization period after commercialization 10 years  
Estimated term of development and commercialization license 25 years  
Development and Commercialization License | Phase I clinical trial
   
Collaborative Agreements disclosures    
Potential milestone payments 5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIClinicalTrialMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
5,000,000imgn_CollaborativeArrangementMilestonePaymentsPotential
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_DevelopmentPhaseAxis
= imgn_PhaseIClinicalTrialMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
Development and Commercialization License | Option To Expand Agreement
   
Collaborative Agreements disclosures    
Number of single-target licenses 1imgn_NumberOfSingleTargetLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
 
Value of collaborators licenses after extension 8,000,000imgn_ValueOfCollaboratorsLicensesAfterExtension
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
8,000,000imgn_ValueOfCollaboratorsLicensesAfterExtension
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
Additional term of extension of the agreement   2 years
Number of development and commercialization licenses   2imgn_NumberOfDevelopmentAndCommercializationLicenses
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember
Development and Commercialization License | Option to expand agreement for one additional year
   
Collaborative Agreements disclosures    
Term of extension of the agreement   1 year
Payments to be made for extension of agreement   $ 4,000,000imgn_PaymentsForCollaboratorsContractExtension
/ us-gaap_CounterpartyNameAxis
= imgn_TakedaOncologyMember
/ imgn_MilestonePaymentsCategoryAxis
= imgn_OptionToExpandAgreementForOneAdditionalYearMember
/ us-gaap_TypeOfArrangementAxis
= imgn_DevelopmentAndCommercializationLicenseMember